# alumshares

> alumshares is a VC fund in Raleigh backing Therapeutics and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Raleigh, United States
- Total investments: 2
- Last investment: Sep 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/alumshares/
- X (Twitter): http://twitter.com/alumshares
- Website: https://alumshares.com
- Facebook: https://www.facebook.com/alumshares

alumshares is a VC fund in Raleigh focused on Therapeutics and Biotechnology. alumshares connects alumni of premier research institutions with previously inaccessible investment opportunities at their Alma Mater.

## Contacts

5 contacts available for alumshares. Shizune tracks 3 team members at alumshares. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/alum-shares?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Product Research | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michael McCord | CEO | 1 | — |
| Chris Keenan | Principal Software Engineer | 0 | — |
| Omar Flores | PhD | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lindy Biosciences | Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies),encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​ | $1.6M | Series A | Sep 18, 2019 | https://www.lindybio.com/ |

1 of 2 investments shown.

## Co-investors
- [BlueTree Allied Angels](https://shizune.co/investors/profile/bluetree-allied-angels) — VC Fund, 2 deals together
- Charleston Angel Conference — VC Fund, 2 deals together
- [IAG Capital Partners](https://shizune.co/investors/profile/iag-capital-partners) — VC Fund, 2 deals together
- [Next Act Fund](https://shizune.co/investors/profile/next-act-fund) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does alumshares invest in?

alumshares invests primarily in Therapeutics, Biotechnology and Product Research startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact alumshares?

Public channels for alumshares include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at alumshares?

The team at alumshares includes Michael McCord (CEO), Chris Keenan (Principal Software Engineer) and Omar Flores (PhD). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co